We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VOLVB:PSECZVolvo AB Class B Analysis

Data as of 2026-03-10 - not real-time

SEK 322.80

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

AB Volvo is trading around SEK 322.8, just above the identified support of 318.45 and below its 20‑day SMA of 343.9. The price action shows a bullish trend direction, yet the RSI of 34.5 indicates oversold conditions while the MACD histogram is negative, signaling short‑term bearish momentum. Volatility over the past 30 days is elevated at 22.7%, but the stock’s beta of 0.42 suggests limited sensitivity to broader market moves. On the fundamentals side, revenue fell 10.6% year‑over‑year, margins remain modest (gross 23.5%, operating 9.3%), and the balance sheet is leveraged with a debt‑to‑equity ratio above 139. Nonetheless, the company generates strong cash flow, supports a 2.59% dividend yield with a 47% payout ratio, and trades at a PE of 19.4 versus an industry average of 29.5. The DCF‑derived fair value of roughly SEK 216 is well below the current price, implying a potential overvaluation from an intrinsic perspective, while the value‑oriented metrics (low PE, solid cash generation) keep the stock in the “value‑blend” zone.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support level
  • Oversold RSI suggesting potential bounce
  • Bearish MACD histogram indicating downside pressure

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • PE substantially below industry average
  • Stable dividend yield with moderate payout ratio
  • Strong operating cash flow despite revenue decline

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High debt load and elevated debt‑to‑equity ratio
  • Diversified global exposure reducing geographic concentration risk
  • Brand strength and recurring revenue from services and financing

Key Metrics & Analysis

Financial Health

Revenue Growth-10.60%
Profit Margin7.19%
P/E Ratio19.4
ROE18.47%
ROA4.45%
Debt/Equity139.39
P/B Ratio3.7
Op. Cash FlowSEK45.6B
Free Cash FlowSEK44.6B
Industry P/E29.5

Technical Analysis

TrendBullish
RSI34.5
SupportSEK 318.45
ResistanceSEK 353.20
MA 20SEK 343.90
MA 50SEK 326.83
MA 200SEK 287.23
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair ValueSEK 216.68
GradeFair
TypeValue
Dividend Yield2.59%

Risk Assessment

Beta0.42
Volatility22.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.